Citation Impact
Citing Papers
Identification of Markers of Taxane Sensitivity Using Proteomic and Genomic Analyses of Breast Tumors from Patients Receiving Neoadjuvant Paclitaxel and Radiation
2010
Microbial metabolic exchange in 3D
2013
Optimal Dissociation Methods Differ for N - and O -Glycopeptides
2020 StandoutNobel
Systemic Delivery of Microencapsulated 3-Bromopyruvate for the Therapy of Pancreatic Cancer
2014 StandoutNobel
Lentiviral Overexpression of GRK6 Alleviates l -Dopa–Induced Dyskinesia in Experimental Parkinson’s Disease
2010
Chemical strategies for tagging and imaging the proteome
2011
Bioimaging of metals by laser ablation inductively coupled plasma mass spectrometry (LA‐ICP‐MS)
2009
Non-motor symptoms of Parkinson's disease: diagnosis and management
2006 Standout
Molecular mechanisms of L-DOPA-induced dyskinesia
2008
Parkinson disease
2017 Standout
Imaging beyond the proteome
2012 StandoutNobel
Putting a spin on the dorsal–ventral divide of the striatum
2004 Standout
Priming for L-DOPA-induced abnormal involuntary movements increases the severity of amphetamine-induced dyskinesia in grafted rats
2009
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
2008 Standout
D 2 Dopamine Receptors Colocalize Regulator of G-Protein Signaling 9-2 (RGS9-2) via the RGS9 DEP Domain, and RGS9 Knock-Out Mice Develop Dyskinesias Associated with Dopamine Pathways
2005
ΔFosB: a molecular switch for long-term adaptation in the brain
2004
Regulation of gene expression and cocaine reward by CREB and ΔFosB
2003
Cognitive modulation of pain: how do attention and emotion influence pain processing?
2002 Standout
Topography of cocaine‐induced gene regulation in the rat striatum: relationship to cortical inputs and role of behavioural context
2003
The Proteomics Identifications (PRIDE) database and associated tools: status in 2013
2012 Standout
When brain clocks lose track of time: cause or consequence of neuropsychiatric disorders
2011 StandoutNobel
Adenosine receptors as therapeutic targets
2006 Standout
Andromeda: A Peptide Search Engine Integrated into the MaxQuant Environment
2011 Standout
Introduction to Computational Proteomics
2007
Signaling by dopamine regulates D2 receptors trafficking at the membrane
2008 StandoutNobel
Continuous dopamine-receptor treatment of Parkinson's disease: scientific rationale and clinical implications
2006
3D Imaging by Mass Spectrometry: A New Frontier
2012
The Neural Basis of Addiction: A Pathology of Motivation and Choice
2005 Standout
Presynaptic Mechanisms of l-DOPA-Induced Dyskinesia: The Findings, the Debate, and the Therapeutic Implications
2014
RGS9–2 Negatively Modulates l-3,4-Dihydroxyphenylalanine-Induced Dyskinesia in Experimental Parkinson's Disease
2007
Endogenous opiates: 1999
2000
Therapeutic potential of adenosine A2A receptor antagonists in Parkinson's disease
2004
Contamination features and health risk of soil heavy metals in China
2015 Standout
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
2016 Standout
Glutamatergic mechanisms in the dyskinesias induced by pharmacological dopamine replacement and deep brain stimulation for the treatment of Parkinson's disease
2011
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies
2001
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Soil amendments for immobilization of potentially toxic elements in contaminated soils: A critical review
2019 Standout
Proteomics: a pragmatic perspective
2010
2008
Effects of levodopa on endocannabinoid levels in rat basal ganglia: implications for the treatment of levodopa‐induced dyskinesias
2003
Illumination of growth, division and secretion by metabolic labeling of the bacterial cell surface
2015 StandoutNobel
Profiling and imaging of tissues by imaging ion mobility‐mass spectrometry
2007
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Persistence of soil organic matter as an ecosystem property
2011 StandoutNature
Potency variation of small-molecule chymase inhibitors across species
2010
The Mesolimbic Dopamine Reward Circuit in Depression
2006 Standout
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
2011 Standout
Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action
2006 Standout
Induction and expression of abnormal involuntary movements is related to the duration of dopaminergic stimulation in 6‐OHDA‐lesioned rats
2011
Microtubule-binding agents: a dynamic field of cancer therapeutics
2010 Standout
Urban environmental geochemistry of trace metals
2005
Molecular imaging by mass spectrometry — looking beyond classical histology
2010
The molecular logic of endocannabinoid signalling
2003 Standout
Chromatin Remodeling Is a Key Mechanism Underlying Cocaine-Induced Plasticity in Striatum
2005
A concise review of mass spectrometry imaging
2010
Dopamine D1 receptors mediate CREB phosphorylation via phosphorylation of the NMDA receptor at Ser897–NR1
2003
Critical Involvement of cAMP/DARPP-32 and Extracellular Signal-Regulated Protein Kinase Signaling in L-DOPA-Induced Dyskinesia
2007
Composition and leaching of construction and demolition waste: Inorganic elements and organic compounds
2014
A Critical Interaction between NR2B and MAGUK in l-DOPA Induced Dyskinesia
2006
Reversal of dyskinesias in an animal model of Parkinson's disease by continuous L-DOPA delivery using rAAV vectors
2005
A rapid MALDI-TOF mass spectrometry workflow for Drosophila melanogaster differential neuropeptidomics
2013 StandoutNobel
Insights into the regulation of protein abundance from proteomic and transcriptomic analyses
2012 Standout
MALDI imaging mass spectrometry: molecular snapshots of biochemical systems
2007
Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesias
2004
Nondopaminergic mechanisms in levodopa‐induced dyskinesia
2005
Discovery and resupply of pharmacologically active plant-derived natural products: A review
2015 Standout
Imaging mass spectrometry
2007
Critical evaluation of soil contamination assessment methods for trace metals
2012
Neurocircuitry of Addiction
2009 Standout
Adenosine receptors and l-DOPA-induced dyskinesia in Parkinson's disease: potential targets for a new therapeutic approach
2003
Proteomic analysis of formalin-fixed paraffin-embedded tissue by MALDI imaging mass spectrometry
2011
A Compact Quadrupole-Orbitrap Mass Spectrometer with FAIMS Interface Improves Proteome Coverage in Short LC Gradients
2020
MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification
2008 Standout
NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease
2013 Standout
Trace metal contamination in urban soils of China
2011
Parkinson's Disease
2003 Standout
Dopamine, learning and motivation
2004 Standout
Remediation of heavy metal(loid)s contaminated soils – To mobilize or to immobilize?
2013 Standout
From the cell to the clinic: A comparative review of the partial D2/D3 receptor agonist and α2-adrenoceptor antagonist, piribedil, in the treatment of Parkinson's disease
2010
Endothelial Proliferation and Increased Blood–Brain Barrier Permeability in the Basal Ganglia in a Rat Model of 3,4-Dihydroxyphenyl-l-Alanine-Induced Dyskinesia
2006
Neurochemistry of Parkinson's disease
2007
The MPTP-treated primate as a model of motor complications in PD
2003
An overview of the composition and application of biomass ash.
2012
Properties of biochar
2018 Standout
Deep proteome and transcriptome mapping of a human cancer cell line
2011 StandoutNobel
Biomass-based chemical looping technologies: the good, the bad and the future
2017 Standout
Mass Spectrometric Imaging for Biomedical Tissue Analysis
2010
Multi‐decadal decline of mercury in the North Atlantic atmosphere explained by changing subsurface seawater concentrations
2012
Adenosine A 2A receptor antagonist treatment of Parkinson’s disease
2003
Fluorescent Sensors for Measuring Metal Ions in Living Systems
2014 Standout
Recycling phosphogypsum and construction demolition waste for cemented paste backfill and its environmental impact
2018 Standout
Ash-related issues during biomass combustion: Alkali-induced slagging, silicate melt-induced slagging (ash fusion), agglomeration, corrosion, ash utilization, and related countermeasures
2015 Standout
Latent Fingerprint Chemical Imaging by Mass Spectrometry
2008 StandoutScience
Molecular Neurobiology of Drug Addiction
2004
Exosomes as drug delivery vehicles for Parkinson's disease therapy
2015 Standout
Lignocellulosic biomass pyrolysis mechanism: A state-of-the-art review
2017 Standout
Mass Spectrometry Analysis and Quantitation of Peptides Presented on the MHC II Molecules of Mouse Spleen Dendritic Cells
2011 StandoutNobel
Mercury as a Global Pollutant: Sources, Pathways, and Effects
2013 Standout
An overview of the composition and application of biomass ash. Part 1. Phase–mineral and chemical composition and classification
2012 Standout
NEURAL MECHANISMS OF ADDICTION: The Role of Reward-Related Learning and Memory
2006 Standout
Chemical Glycoproteomics
2016 StandoutNobel
Works of Malin Andersson being referenced
Measurements and Modeling of the Air-Sea Exchange of Mercury
2009
Putaminal Upregulation of FosB/ΔFosB-Like Immunoreactivity in Parkinson's Disease Patients with Dyskinesia
2011
Building materials as a source of PCB pollution in Bergen, Norway
2004
Alterations in Cortical and Basal Ganglia Levels of Opioid Receptor Binding in a Rat Model of l-DOPA-Induced Dyskinesia
2001
Striatal fosB Expression Is Causally Linked with l-DOPA-Induced Abnormal Involuntary Movements and the Associated Upregulation of Striatal Prodynorphin mRNA in a Rat Model of Parkinson's Disease
1999
A Novel Histology-directed Strategy for MALDI-MS Tissue Profiling That Improves Throughput and Cellular Specificity in Human Breast Cancer
2006
The extended substrate specificity of the human mast cell chymase reveals a serine protease with well-defined substrate recognition profile
2008
Identification of proteins directly from tissue: in situ tryptic digestions coupled with imaging mass spectrometry
2007
MALDI mass spectrometry based molecular phenotyping of CNS glial cells for prediction in mammalian brain tissue
2011
Expression pattern of JunD after acute or chronic l-DOPA treatment: Comparison with ΔFosB
2006
Element levels in birch and spruce wood ashes — green energy?
2008
Time course of striatal ΔFosB‐like immunoreactivity and prodynorphin mRNA levels after discontinuation of chronic dopaminomimetic treatment
2003
Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease
2002
Changes in the regional and compartmental distribution of FosB- and JunB-like immunoreactivity induced in the dopamine-denervated rat striatum by acute or chronic L-DOPA treatment
1999
Processing MALDI mass spectra to improve mass spectral direct tissue analysis
2006
Persistent changes in striatal gene expression induced by long‐term l ‐DOPA treatment in a rat model of Parkinson's disease
2001
Fine Mapping the Spatial Distribution and Concentration of Unlabeled Drugs within Tissue Micro-Compartments Using Imaging Mass Spectrometry
2010
Imaging mass spectrometry of proteins and peptides: 3D volume reconstruction
2007
cAMP Response Element-Binding Protein Is Required for Dopamine-Dependent Gene Expression in the Intact But Not the Dopamine-Denervated Striatum
2001
Heat Stabilization of the Tissue Proteome: A New Technology for Improved Proteomics
2009
Geochemistry of urban surface soils — Monitoring in Trondheim, Norway
2010
Direct Molecular Analysis of Whole-Body Animal Tissue Sections by Imaging MALDI Mass Spectrometry
2006